B7-H3 expression in colorectal cancer: Nuclear localization strongly predicts poor outcome in colon cancer

B7-H3 Contributes to the Development of Pathogenic Th2 Cells in a Murine Model of Asthma

(2014) O. Nagashima et al.   JOURNAL OF IMMUNOLOGY

B7-H3 Silencing Increases Paclitaxel Sensitivity by Abrogating Jak2/Stat3 Phosphorylation

(2011) H. Liu et al.   MOLECULAR CANCER THERAPEUTICS

B7–H3 Ligand Expression by Primary Breast Cancer and Associated With Regional Nodal Metastasis

(2010) Takaaki Arigami et al.   ANNALS OF SURGERY

Clinical significance and regulation of the costimulatory molecule B7-H3 in human colorectal carcinoma

(2010) Jing Sun et al.   CANCER IMMUNOLOGY IMMUNOTHERAPY

High levels of microRNA-21 in the stroma of colorectal cancers predict short disease-free survival in stage II colon cancer patients

(2010) Boye Schnack Nielsen et al.   CLINICAL & EXPERIMENTAL METASTASIS

Nuclear S100A4 is a novel prognostic marker in colorectal cancer

(2010) Kjetil Boye et al.   EUROPEAN JOURNAL OF CANCER

Low molecular weight heat shock protein HSP27 is a prognostic indicator in rectal cancer but not colon cancer

(2010) E. M. Tweedle et al.   GUT

Estimates of worldwide burden of cancer in 2008: GLOBOCAN 2008

(2010) Jacques Ferlay et al.   INTERNATIONAL JOURNAL OF CANCER

Tumor associated endothelial expression of B7-H3 predicts survival in ovarian carcinomas

(2010) Xingxing Zang et al.   MODERN PATHOLOGY

Nuclear trafficking of the epidermal growth factor receptor family membrane proteins

(2010) Y-N Wang et al.   ONCOGENE

Expression of the costimulatory molecule B7-H3 is associated with prolonged survival in human pancreatic cancer

(2009) Martin Loos et al.   BMC CANCER

Clinical importance of B7-H3 expression in human pancreatic cancer

(2009) I Yamato et al.   BRITISH JOURNAL OF CANCER

B7-H3 is a potent inhibitor of human T-cell activation: No evidence for B7-H3 and TREML2 interaction

(2009) Judith Leitner et al.   EUROPEAN JOURNAL OF IMMUNOLOGY

Improved Overall Survival With Oxaliplatin, Fluorouracil, and Leucovorin As Adjuvant Treatment in Stage II or III Colon Cancer in the MOSAIC Trial

(2009) Thierry André et al.   JOURNAL OF CLINICAL ONCOLOGY

Revised TN Categorization for Colon Cancer Based on National Survival Outcomes Data

(2009) Leonard L. Gunderson et al.   JOURNAL OF CLINICAL ONCOLOGY

Importins and Beyond: Non-Conventional Nuclear Transport Mechanisms

(2009) Kylie M. Wagstaff et al.   TRAFFIC

T-cell Co-regulatory Molecule Expression in Renal Angiomyolipoma and Pulmonary Lymphangioleiomyomatosis

(2009) Stephen A. Boorjian et al.   UROLOGY

Nuclear and Cytoplasmic Expression of ER 1, ER 2, and ER 5 Identifies Distinct Prognostic Outcome for Breast Cancer Patients

(2008) A. M. Shaaban et al.   CLINICAL CANCER RESEARCH

Tumor Cell and Tumor Vasculature Expression of B7-H3 Predict Survival in Clear Cell Renal Cell Carcinoma

(2008) P. L. Crispen et al.   CLINICAL CANCER RESEARCH

T-Cell Coregulatory Molecule Expression in Urothelial Cell Carcinoma: Clinicopathologic Correlations and Association with Survival

(2008) S. A. Boorjian et al.   CLINICAL CANCER RESEARCH

The Immunoregulatory Protein Human B7H3 is a Tumor-Associated Antigen that Regulates Tumor Cell Migration and Invasion

(2008) Yih-Wen Chen et al.   CURRENT CANCER DRUG TARGETS

Trafficking of receptor tyrosine kinases to the nucleus

(2008) Graham Carpenter et al.   EXPERIMENTAL CELL RESEARCH

Triggering receptor expressed on myeloid cell-like transcript 2 (TLT-2) is a counter-receptor for B7-H3 and enhances T cell responses

(2008) M. Hashiguchi et al.   PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA